Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

About this trial

This is a clinical trial to investigate the safety and effect of a stem cell intervention in individuals with traumatic spinal cord injury. The cells used are a type of stem cell (mesenchymal) processed from the participant's own fat (adipose) tissue. The cells are removed from fat tissue, expanded, and then injected back into the fluid surrounding the spinal cord. Participants will undergo follow-up measurement for up to 2 years, including testing for motor, sensory and other neurological functions, including bladder and bowel function. If included in the sudy, participants will be randomly assigned to one of two study groups: 1) receiving the stem cell injection; or 2) receiving the stem cell injection after six months of standard medical management, including occupational and physical therapy.